Table 2.

NK cell numbers and function in JAK3-deficient SCID patients




Before transplantation

After transplantation

Time of study*
CD16+, cells per mm3
NK activity, % target lysis
CD16+, cells per mm3
NK activity, % target lysis
Patient no.       
1   2   29   0.0   1598   71.0  
2   7   0   ND   60   1.7  
3   12   204   6.8   54   ND  
4   2   15   0.0   186   2.5  
5   6   29   ND   319   25.9  
6   8   31   1.4   58   0.0  
7   NA   22   ND   NA   NA  
8   8   NA   NA   55   4.0  
9   8   NA   NA   60   3.1  
10   2   NA   NA   124   0.6  
Controls
 
NA
 
87-1189
 
38.9 ± 13.9§
 
87-1189
 
38.9 ± 13.9§
 



Before transplantation

After transplantation

Time of study*
CD16+, cells per mm3
NK activity, % target lysis
CD16+, cells per mm3
NK activity, % target lysis
Patient no.       
1   2   29   0.0   1598   71.0  
2   7   0   ND   60   1.7  
3   12   204   6.8   54   ND  
4   2   15   0.0   186   2.5  
5   6   29   ND   319   25.9  
6   8   31   1.4   58   0.0  
7   NA   22   ND   NA   NA  
8   8   NA   NA   55   4.0  
9   8   NA   NA   60   3.1  
10   2   NA   NA   124   0.6  
Controls
 
NA
 
87-1189
 
38.9 ± 13.9§
 
87-1189
 
38.9 ± 13.9§
 

ND indicates not done; and NA, not applicable.

*

Number of years after stem cell transplantation (patient 1, unrelated cord blood transplantation; patient 6, T cell—depleted HLA-haploidentical transplantation number 1; single T cell—depleted HLA-haploidentical transplantation for patients 2, 4, 8, 9, and 10; single HLA identical transplantation for patients 3 and 5; patient 7 is deceased) when posttransplantation experiments were performed.

Percent specific K562 lysis at effector-target (E/T) ratio 50:1. Results were similar at other E/T ratios.

Values are the 95% confidence interval for 167 control subjects.

§

Mean ± SD; percent specific target lysis by healthy volunteer cells for the 17 experiments shown.

Close Modal

or Create an Account

Close Modal
Close Modal